Altimmune(US:ALT) Globenewswireยท2025-05-06 11:30Core Viewpoint - Altimmune, Inc. is set to report its first quarter 2025 financial results on May 13, 2025, and will host a conference call to discuss these results and provide a business update [1]. Group 1: Financial Results Announcement - The company will announce its first quarter 2025 financial results on May 13, 2025 [1]. - A conference call will be held at 8:30 am E.T. on the same day to discuss the financial results [1]. - The conference call will be available via live webcast on Altimmune's Investor Relations website [1]. Group 2: Company Overview - Altimmune is a late clinical-stage biopharmaceutical company focused on developing next-generation peptide-based therapeutics [3]. - The company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist aimed at treating obesity, MASH, alcohol use disorder, and alcohol-related liver disease [3].